Journal article

Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9)

LM Ludbrook, P Bernard, S Bagheri-Fam, J Ryan, R Sekido, D Wilhelm, R Lovell-Badge, VR Harley

Endocrinology | Published : 2012

Abstract

Human DAX1 duplications cause dosage-sensitive sex reversal (DSS) whereby chromosomally XY individuals can develop as females due to gonadal dysgenesis. However, the mechanism of DSS-adrenal hypoplasia congenita on X, gene 1 (DAX1) action in the fetal testis is unknown. We show that in fetal testes from XY Dax1-overexpressing transgenic mice, the expression of the key testis-promoting gene sex-determining region on Y (SRY)-box-9 (Sox9) is reduced. Moreover, in XY Sox9 heterozygotes, in which testis development is usually normal, Dax1 overexpression results in ovotestes, suggesting a DAX1-SOX9 antagonism. The ovarian portion of the XY ovotestes was characterized by expression of the granulosa..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Medical Research Council


Funding Acknowledgements

This work was supported by National Health and Medical Research Council Program Grants 334314 and 546517 (to V. R. H.) and Fellowships 441102 and 1020034 (to V. R. H.), Australian Postgraduate Award (to L. M. L.) and Monash University Travel Award (to L. M. L.), and the U.K. Medical Research Council Grant U117512772 (to R.L.-B.). This work was also supported by the Victorian Government's Operational Infrastructure Support Program Prince Henry's Institute audit number 11-13.